Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Institut Curie Stories

2013-12-17 08:28:03

PARIS and SAN FRANCISCO, December 17, 2013 /PRNewswire/ -- A breakthrough image management platform for scientists Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, and Strand Scientific Intelligence, Inc. (Strand) announce the launch of the Curie Image Database (CID), a breakthrough image analysis and management platform that they developed jointly over the last two years at the Cell and Tissue Imaging Core...

2012-09-04 02:29:36

PARIS, Sept. 4, 2012 /PRNewswire/ -- Four advanced radiotherapy treatment systems from Varian Medical Systems (NYSE: VAR) have been ordered by Institut Curie, one of Europe's foremost comprehensive cancer centers, to replace older and less capable machines. Institut Curie, which operates at three sites in Paris, is acquiring three Varian TrueBeam(TM) systems and a Novalis Tx(TM) machine to extend the range of modern cancer treatments offered to patients. The largest hospital in the...

2012-07-05 10:35:24

Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found. The researchers were able to reprogram the asthma-promoting cells (called Th2 (T-helper 2) cells) after identifying an enzyme that modifies the DNA of these cells. The enzyme could be a target for the development of new treatments for chronic inflammatory diseases, in particular allergic asthma, caused by...

2010-01-11 03:02:00

PARIS and MARSEILLE, France, January 11 /PRNewswire-FirstCall/ -- The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie. The aim of this collaboration is to...